Skip to main content
Erschienen in: Neurocritical Care 3/2014

01.12.2014 | Review Article

The Subarachnoid Hemorrhage International Trialists (SAHIT) Repository: Advancing Clinical Research in Subarachnoid Hemorrhage

verfasst von: Blessing N. R. Jaja, Daniel Attalla, R. Loch Macdonald, Tom A. Schweizer, Michael D. Cusimano, Nima Etminan, Daniel Hanggi, David Hasan, S. Claiborne Johnston, Peter Le Roux, Benjamin Lo, Ada Louffat-Olivares, Stephan Mayer, Andrew Molyneux, Adam Noble, Audrey Quinn, Thomas Schenk, Julian Spears, Jeffrey Singh, Michael Todd, James Torner, Ming Tseng, William van den Bergh, Mervyn D. I. Vergouwen, George K. C. Wong

Erschienen in: Neurocritical Care | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Researchers and other stakeholders continue to express concern about the failure of randomized clinical trials (RCT) in subarachnoid hemorrhage (SAH) to show efficacy of new treatments. Pooled data may be particularly useful to generate hypotheses about causes of poor outcomes and reasons for failure of RCT in SAH, and strategies to improve them. Investigators conducting SAH research collaborated to share data with the intent to develop a large repository of pooled individual patient data for exploratory analysis and testing of new hypotheses relevant to improved trial design and analysis in SAH. This repository currently contains information on 11,443 SAH patients from 14 clinical databases, of which 9 are datasets of recent RCTs and 5 are datasets of prospective observational studies and hospital registries. Most patients were managed in the last 15 years. Data validation and quality checks have been conducted and are satisfactory. Data is available on demographic, clinical, neuroimaging, and laboratory results and various outcome measures. We have compiled the largest known dataset of patients with SAH. The SAHIT repository may be an important resource for advancing clinical research in SAH and will benefit from contributions of additional datasets.
Literatur
1.
Zurück zum Zitat Korja M, Silventoinen K, Laatikainen T, Jousilahti P, Salomaa V, Kaprio J. Cause-specific mortality of 1-year survivors of subarachnoid hemorrhage. Neurology. 2013;80:481–6.PubMedCentralPubMedCrossRef Korja M, Silventoinen K, Laatikainen T, Jousilahti P, Salomaa V, Kaprio J. Cause-specific mortality of 1-year survivors of subarachnoid hemorrhage. Neurology. 2013;80:481–6.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41:519–36.CrossRef Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41:519–36.CrossRef
3.
Zurück zum Zitat Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8:635–42.PubMedCrossRef Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8:635–42.PubMedCrossRef
4.
Zurück zum Zitat Lovelock CE, Rinkel GJE, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage population-based study and systematic review. Neurology. 2010;74:1494–501.PubMedCentralPubMedCrossRef Lovelock CE, Rinkel GJE, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage population-based study and systematic review. Neurology. 2010;74:1494–501.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994–1025.PubMedCrossRef Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994–1025.PubMedCrossRef
6.
Zurück zum Zitat Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636–42.PubMedCentralPubMedCrossRef Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636–42.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267–74.PubMedCrossRef Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267–74.PubMedCrossRef
8.
Zurück zum Zitat Macdonald RL, Jaja B, Cusimano MD, et al. SAHIT investigators-on the outcome of some subarachnoid hemorrhage clinical trials. Transl Stroke Res. 2013;4:286–96.PubMedCrossRef Macdonald RL, Jaja B, Cusimano MD, et al. SAHIT investigators-on the outcome of some subarachnoid hemorrhage clinical trials. Transl Stroke Res. 2013;4:286–96.PubMedCrossRef
9.
Zurück zum Zitat Macdonald RL, Cusimano MD, Etminan N, et al. Subarachnoid Hemorrhage International Trialists data repository (SAHIT). World Neurosurg. 2013;79:418–22.PubMedCrossRef Macdonald RL, Cusimano MD, Etminan N, et al. Subarachnoid Hemorrhage International Trialists data repository (SAHIT). World Neurosurg. 2013;79:418–22.PubMedCrossRef
10.
Zurück zum Zitat Maas AI, Steyerberg EW, Marmarou A, et al. IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics. 2010;7:127–34.PubMedCrossRef Maas AI, Steyerberg EW, Marmarou A, et al. IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics. 2010;7:127–34.PubMedCrossRef
11.
Zurück zum Zitat Bath PM, Lees KR, Schellinger PD, et al. Statistical analysis of the primary outcome in acute stroke trials. Stroke. 2012;43:1171–8.PubMedCrossRef Bath PM, Lees KR, Schellinger PD, et al. Statistical analysis of the primary outcome in acute stroke trials. Stroke. 2012;43:1171–8.PubMedCrossRef
12.
Zurück zum Zitat van den Bergh WM, Algra A, van KF, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005;36:1011–5.CrossRef van den Bergh WM, Algra A, van KF, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005;36:1011–5.CrossRef
13.
Zurück zum Zitat Wong GKC, Poon WS, Chan MTV, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH) a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke. 2010;41:921–6.PubMedCrossRef Wong GKC, Poon WS, Chan MTV, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH) a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke. 2010;41:921–6.PubMedCrossRef
14.
Zurück zum Zitat Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39:3015–21.PubMedCrossRef Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39:3015–21.PubMedCrossRef
15.
Zurück zum Zitat Todd MM, Hindman BJ, Clarke WR, Torner JC. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005;352:135–45.PubMedCrossRef Todd MM, Hindman BJ, Clarke WR, Torner JC. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005;352:135–45.PubMedCrossRef
16.
Zurück zum Zitat Johnston SC, McDougall CG, Gholkar A. The MAPS trial—Matrix and Platinum Science-clinical trials. Colorado: Colorado Spring; 2011. Johnston SC, McDougall CG, Gholkar A. The MAPS trial—Matrix and Platinum Science-clinical trials. Colorado: Colorado Spring; 2011.
17.
Zurück zum Zitat Etminan N, Beseoglu K, Eicker SO, Turowski B, Steiger HJ, Hanggi D. Prospective, randomized, open-label phase II trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage. Stroke. 2013;44:2162–8.PubMedCrossRef Etminan N, Beseoglu K, Eicker SO, Turowski B, Steiger HJ, Hanggi D. Prospective, randomized, open-label phase II trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage. Stroke. 2013;44:2162–8.PubMedCrossRef
18.
Zurück zum Zitat Noble AJ, Schenk T. Which variables help explain the poor health-related quality of life after subarachnoid hemorrhage? A meta-analysis. Neurosurgery. 2010;66:772–83.PubMedCrossRef Noble AJ, Schenk T. Which variables help explain the poor health-related quality of life after subarachnoid hemorrhage? A meta-analysis. Neurosurgery. 2010;66:772–83.PubMedCrossRef
19.
Zurück zum Zitat Helbok R, Kurtz P, Vibbert M, Schmidt MJ, Fernandez L, Lantigua H, et al. Early neurological deterioration after subarachnoid haemorrhage: risk factors and impact on outcome. J Neurol Neurosurg Psychiatry. 2013;84:266–70.PubMedCentralPubMedCrossRef Helbok R, Kurtz P, Vibbert M, Schmidt MJ, Fernandez L, Lantigua H, et al. Early neurological deterioration after subarachnoid haemorrhage: risk factors and impact on outcome. J Neurol Neurosurg Psychiatry. 2013;84:266–70.PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Smith ML, Abrahams JM, Chandela S, Smith MJ, Hurst RW, Le Roux PD. Subarachnoid hemorrhage on computed tomography scanning and the development of cerebral vasospasm: the Fisher grade revisited. Surg Neurol. 2005;63:229–35.PubMedCrossRef Smith ML, Abrahams JM, Chandela S, Smith MJ, Hurst RW, Le Roux PD. Subarachnoid hemorrhage on computed tomography scanning and the development of cerebral vasospasm: the Fisher grade revisited. Surg Neurol. 2005;63:229–35.PubMedCrossRef
21.
Zurück zum Zitat Reilly C, Amidei C, Tolentino J, Jahromi BS, MacDonald RL. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004;101:255–61.PubMedCrossRef Reilly C, Amidei C, Tolentino J, Jahromi BS, MacDonald RL. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004;101:255–61.PubMedCrossRef
22.
Zurück zum Zitat Drake CG, Hunt WE, Sano K, Kassell N, Teasdale G, Pertuiset B, et al. Report of World Federation of Neurological Surgeons committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988;68:985–6. Drake CG, Hunt WE, Sano K, Kassell N, Teasdale G, Pertuiset B, et al. Report of World Federation of Neurological Surgeons committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988;68:985–6.
23.
Zurück zum Zitat Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20.PubMedCrossRef Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20.PubMedCrossRef
24.
Zurück zum Zitat Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1–9.PubMedCrossRef Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1–9.PubMedCrossRef
25.
Zurück zum Zitat Hijdra A, Brouwers PJ, Vermeulen M, van GJ. Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke. 1990;21:1156–61.PubMedCrossRef Hijdra A, Brouwers PJ, Vermeulen M, van GJ. Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke. 1990;21:1156–61.PubMedCrossRef
26.
Zurück zum Zitat Ali M, Bath PM, Curram J, et al. The virtual international stroke trials archive. Stroke. 2007;38:1905–10.PubMedCrossRef Ali M, Bath PM, Curram J, et al. The virtual international stroke trials archive. Stroke. 2007;38:1905–10.PubMedCrossRef
27.
Zurück zum Zitat Marmarou A, Lu J, Butcher I, et al. IMPACT database of traumatic brain injury: design and description. J Neurotrauma. 2007;24:239–50.PubMedCrossRef Marmarou A, Lu J, Butcher I, et al. IMPACT database of traumatic brain injury: design and description. J Neurotrauma. 2007;24:239–50.PubMedCrossRef
28.
Zurück zum Zitat Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: surgical results. J Neurosurg. 1990;73:37–47.PubMedCrossRef Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: surgical results. J Neurosurg. 1990;73:37–47.PubMedCrossRef
29.
Zurück zum Zitat Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: overall management results. J Neurosurg. 1990;73:18–36.PubMedCrossRef Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: overall management results. J Neurosurg. 1990;73:18–36.PubMedCrossRef
30.
Zurück zum Zitat Johnston SC, Dowd CF, Higashida RT, Lawton MT, Duckwiler GR, Gress DR. Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) Study. Stroke. 2008;39:120–5.PubMedCrossRef Johnston SC, Dowd CF, Higashida RT, Lawton MT, Duckwiler GR, Gress DR. Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) Study. Stroke. 2008;39:120–5.PubMedCrossRef
31.
Zurück zum Zitat Tseng MY, Hutchinson PJ, Richards HK, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. J Neurosurg. 2009;111:171–80.PubMedCrossRef Tseng MY, Hutchinson PJ, Richards HK, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. J Neurosurg. 2009;111:171–80.PubMedCrossRef
32.
Zurück zum Zitat Tseng MY, Hutchinson PJ, Turner CL, et al. Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial. J Neurosurg. 2007;107:1092–100.PubMedCrossRef Tseng MY, Hutchinson PJ, Turner CL, et al. Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial. J Neurosurg. 2007;107:1092–100.PubMedCrossRef
Metadaten
Titel
The Subarachnoid Hemorrhage International Trialists (SAHIT) Repository: Advancing Clinical Research in Subarachnoid Hemorrhage
verfasst von
Blessing N. R. Jaja
Daniel Attalla
R. Loch Macdonald
Tom A. Schweizer
Michael D. Cusimano
Nima Etminan
Daniel Hanggi
David Hasan
S. Claiborne Johnston
Peter Le Roux
Benjamin Lo
Ada Louffat-Olivares
Stephan Mayer
Andrew Molyneux
Adam Noble
Audrey Quinn
Thomas Schenk
Julian Spears
Jeffrey Singh
Michael Todd
James Torner
Ming Tseng
William van den Bergh
Mervyn D. I. Vergouwen
George K. C. Wong
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe 3/2014
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-014-9990-y

Weitere Artikel der Ausgabe 3/2014

Neurocritical Care 3/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.